Metastatic carcinoma of unknown origin treatment with vinorelbine; gemcetabine and methotrexate

Waqar, Al Kubaisy; Ahmad Abbas, Al Azawi.
JBMS-Journal of the Bahrain Medical Society. 2003; 15 (4): 199-203
en Inglés | IMEMR | ID: emr-62425

Documentos relacionados

  1. Clearing the Fog surrounding Chemobrain.
  2. Impacts of methotrexate on survival, dendrite development, and synapse formation of cortical neurons.
  3. Functional Group-Assisted Fluorescence Sensing Platform for Nanomolar-Level Detection of an Antineoplastic Drug and a Neurotransmitter from Environmental Water and Human Biofluids.
  4. Therapeutic Effect of Colony Stimulating Factor 1 Receptor Kinase Inhibitor, JTE-952, on Methotrexate-Refractory Pathology in a Rat Model of Rheumatoid Arthritis.
  5. Comparison of Sodium Bicarbonate and Lactated Ringers Hydration for High-dose Methotrexate Chemotherapy in Children.
  6. Delivery of Small Molecules by Syndiotactic Peptides for Breast Cancer Therapy.
  7. Evaluation of an oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization.
  8. Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review.
  9. Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy.
  10. Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study.